Kronos Bio, Inc.
KRONDelisted Jun 20, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001741830
Kronos Bio, Inc. was delisted on Jun 20, 2025; its insiders filed their last Form 4 on Jun 20, 2025; 47 institutions reported holding it in 13F filings for Q1 2025, worth $15.8M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Kronos Bio, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- −2 vs. Q3 2023
- Shares held
- 26.7M
- −3.51M (−11.6%) vs. Q3 2023
- Total value
- $33.4M
- −$5.88M (−15.0%) vs. Q3 2023
- New holders
- 7
- 12 more added
- Sold out
- 9
- 18 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 47 | $15.8M |
| Q4 2024 | 56 | $18.7M |
| Q3 2024 | 53 | $19.7M |
| Q2 2024 | 56 | $25.6M |
| Q1 2024 | 58 | $28.2M |
| Q4 2023 | 60 | $33.4M |
| Q3 2023 | 63 | $39.3M |
| Q2 2023 | 80 | $54.3M |
| Q1 2023 | 87 | $47.3M |
| Q4 2022 | 97 | $55.9M |
| Q3 2022 | 96 | $120.8M |
| Q2 2022 | 94 | $134.4M |
| Q1 2022 | 96 | $282.0M |
| Q4 2021 | 81 | $557.8M |
| Q3 2021 | 83 | $811.6M |
| Q2 2021 | 77 | $956.8M |
| Q1 2021 | 71 | $1.05B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Kronos Bio, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 211 | $0 | 0.00% | −6,303−96.8% | Reduced |
| Simplex Trading, LLC | 691 | $0 | 0.00% | +691 | New |
| Tower Research Capital LLC (TRC) | 72 | $90 | 0.00% | +72 | New |
| Wells Fargo & Company | 341 | $426 | 0.00% | +18+5.6% | Added |
| JPMorgan Chase & Co | 350 | $438 | 0.00% | −1,171−77.0% | Reduced |
| Citigroup Inc | 400 | $500 | 0.00% | −31−7.2% | Reduced |
| Dakota Community Bank & Trust NA | 943 | $1.18K | 0.01% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 1,874 | $2.34K | 0.00% | −4,850−72.1% | Reduced |
| Rhumbline Advisers | 2,088 | $2.61K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5,773 | $7.22K | 0.00% | +29+0.5% | Added |
| Pathstone Holdings, LLC | 12,034 | $15.0K | 0.00% | +12,034 | New |
| Ground Swell Capital, LLC | 15,260 | $19.1K | 0.07% | +15,260 | New |
| Barclays PLC | 16,128 | $20.2K | 0.00% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 16,150 | $20.2K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 16,500 | $20.6K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 16,618 | $20.8K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 19,079 | $23.8K | 0.00% | −12,727−40.0% | Reduced |
| Goldman Sachs Group Inc | 19,643 | $24.6K | 0.00% | −7,769−28.3% | Reduced |
| Gsa Capital Partners LLP | 25,146 | $31.0K | 0.00% | −29,375−53.9% | Reduced |
| Bluefin Capital Management, LLC | 25,100 | $31.1K | 0.00% | +25,100 | New |
| XTX Topco Ltd | 32,032 | $40.0K | 0.01% | +10,818+51.0% | Added |
| HSBC Holdings PLC | 38,368 | $45.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 38,537 | $48.2K | 0.00% | −4,157−9.7% | Reduced |
| Cornercap Investment Counsel Inc | 41,351 | $51.7K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 45,443 | $56.8K | 0.00% | +45,443 | New |
| Forefront Analytics, LLC | 49,168 | $61.5K | 0.03% | +9,200+23.0% | Added |
| Coastal Bridge Advisors, LLC | 51,968 | $65.0K | 0.02% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 67,100 | $83.9K | 0.02% | −941−1.4% | Reduced |
| Samsara BioCapital, LLC | 78,131 | $97.7K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 92,673 | $115.8K | 0.00% | 00.0% | Unchanged |
| Kennedy Capital Management, Inc. | 108,229 | $135.3K | 0.00% | −830−0.8% | Reduced |
| Casdin Capital, LLC | 123,839 | $154.8K | 0.02% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 138,213 | $172.8K | 0.00% | −61,925−30.9% | Reduced |
| Squarepoint Ops LLC | 153,422 | $191.8K | 0.00% | +18,539+13.7% | Added |
| State Street Corp | 178,301 | $222.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 197,960 | $247.4K | 0.00% | +44,614+29.1% | Added |
| Two Sigma Advisers, LP | 214,700 | $268.4K | 0.00% | −28,800−11.8% | Reduced |
| CM Management, LLC | 250,000 | $312.5K | 0.25% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 254,987 | $318.7K | 0.00% | −115,780−31.2% | Reduced |
| Privium Fund Management (UK) Ltd | 292,182 | $365.2K | 0.25% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 293,530 | $366.9K | 0.00% | +242,716+477.7% | Added |
| Bridgeway Capital Management, LLC | 293,675 | $367.1K | 0.01% | +34,900+13.5% | Added |
| Choate Investment Advisors | 308,697 | $385.9K | 0.01% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 327,976 | $410.0K | 0.22% | −845−0.3% | Reduced |
| FMR LLC | 365,200 | $456.5K | 0.00% | +360,508+7,683.5% | Added |
| Cerity Partners LLC | 410,796 | $513.5K | 0.00% | +410,796 | New |
| Geode Capital Management, LLC | 428,522 | $535.8K | 0.00% | +18,205+4.4% | Added |
| Acadian Asset Management LLC | 660,941 | $825.0K | 0.00% | +45,996+7.5% | Added |
| Artal Group S.A. | 842,954 | $1.05M | 0.04% | −700,000−45.4% | Reduced |
| Millennium Management LLC | 848,000 | $1.06M | 0.00% | −147,984−14.9% | Reduced |
| Renaissance Technologies LLC | 912,926 | $1.14M | 0.00% | −88,774−8.9% | Reduced |
| BlackRock Inc. | 1,068,504 | $1.34M | 0.00% | −312,848−22.6% | Reduced |
| Wildcat Capital Management, LLC | 1,297,959 | $1.62M | 0.56% | 00.0% | Unchanged |
| Alphabet Inc. | 1,438,232 | $1.80M | 0.08% | 00.0% | Unchanged |
| Partners Capital Investment Group, LLP | 1,665,797 | $2.08M | 0.05% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,700,677 | $2.13M | 0.00% | +12,312+0.7% | Added |
| Perceptive Advisors LLC | 1,752,745 | $2.19M | 0.05% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 2,765,314 | $3.46M | 4.12% | 00.0% | Unchanged |
| BVF Inc | 2,905,043 | $3.63M | 0.09% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 3,818,283 | $4.77M | 3.87% | 00.0% | Unchanged |
| Nextech Invest AG | 0 | $0 | 0.00% | −1,451,537−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −917,436−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −718,739−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −173,877−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2,056−100.0% | Sold out |
| Cary Street Partner Investment Advisory LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −813−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Pathstone Family Office, LLC | – | – | – | – | Not filed |